China Shineway Pharmaceutical Group Limited (HKG:2877)
Hong Kong
· Delayed Price · Currency is HKD 9.85
+0.07 (0.72%)
Apr 29, 2026, 4:08 PM HKT
HKG:2877 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 7,388 | 6,496 | 7,290 | 5,492 | 5,733 | 5,205 | Upgrade
|
| Market Cap Growth | 24.43% | -10.88% | 32.74% | -4.22% | 10.16% | 29.89% | Upgrade
|
| Enterprise Value | -665 | -758 | 967 | 24 | 537 | 224 | Upgrade
|
| Last Close Price | 9.78 | 8.60 | 9.04 | 6.39 | 6.30 | 5.37 | Upgrade
|
| PE Ratio | 6.99 | 6.15 | 8.15 | 5.14 | 7.02 | 7.62 | Upgrade
|
| Forward PE | 6.75 | 7.00 | 6.29 | 5.10 | 7.57 | 6.45 | Upgrade
|
| PS Ratio | 2.12 | 1.86 | 1.81 | 1.10 | 1.28 | 1.32 | Upgrade
|
| PB Ratio | 0.82 | 0.72 | 0.92 | 0.71 | 0.80 | 0.72 | Upgrade
|
| P/TBV Ratio | 0.84 | 0.74 | 0.94 | 0.73 | 0.82 | 0.75 | Upgrade
|
| P/FCF Ratio | 6.82 | 5.99 | 8.32 | 6.32 | 5.17 | 6.96 | Upgrade
|
| P/OCF Ratio | 5.66 | 4.98 | 7.11 | 5.35 | 4.57 | 6.03 | Upgrade
|
| EV/Sales Ratio | - | - | 0.24 | 0.01 | 0.12 | 0.06 | Upgrade
|
| EV/EBITDA Ratio | - | - | 1.02 | 0.02 | 0.54 | 0.26 | Upgrade
|
| EV/EBIT Ratio | - | - | 1.09 | 0.02 | 0.67 | 0.34 | Upgrade
|
| EV/FCF Ratio | -0.61 | - | 1.10 | 0.03 | 0.48 | 0.30 | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.04 | 0.05 | 0.04 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.44 | 0.44 | 0.38 | 0.29 | 0.01 | 0.02 | Upgrade
|
| Debt / FCF Ratio | 0.34 | 0.34 | 0.42 | 0.38 | 0.01 | 0.02 | Upgrade
|
| Net Debt / Equity Ratio | -0.90 | -0.90 | -0.82 | -0.80 | -0.79 | -0.71 | Upgrade
|
| Net Debt / EBITDA Ratio | -9.78 | -9.78 | -6.90 | -5.51 | -5.68 | -5.95 | Upgrade
|
| Net Debt / FCF Ratio | -7.43 | -7.43 | -7.47 | -7.12 | -5.14 | -6.88 | Upgrade
|
| Asset Turnover | 0.30 | 0.30 | 0.39 | 0.51 | 0.51 | 0.45 | Upgrade
|
| Inventory Turnover | 1.16 | 1.16 | 1.11 | 1.44 | 1.63 | 1.58 | Upgrade
|
| Quick Ratio | 3.42 | 3.42 | 3.17 | 2.97 | 3.66 | 4.62 | Upgrade
|
| Current Ratio | 3.71 | 3.71 | 3.51 | 3.35 | 4.07 | 5.19 | Upgrade
|
| Return on Equity (ROE) | 12.23% | 12.23% | 11.59% | 14.45% | 11.77% | 9.52% | Upgrade
|
| Return on Assets (ROA) | 4.09% | 4.09% | 5.33% | 6.81% | 5.78% | 4.63% | Upgrade
|
| Return on Invested Capital (ROIC) | 61.86% | 47.62% | 44.71% | 54.89% | 36.93% | 20.95% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.30% | 8.30% | 11.00% | 13.60% | 10.90% | 8.80% | Upgrade
|
| Earnings Yield | 14.31% | 16.27% | 12.26% | 19.45% | 14.25% | 13.13% | Upgrade
|
| FCF Yield | 14.67% | 16.69% | 12.02% | 15.81% | 19.33% | 14.37% | Upgrade
|
| Dividend Yield | 5.51% | 6.08% | 6.35% | 7.24% | 5.75% | 8.92% | Upgrade
|
| Payout Ratio | 37.37% | 37.37% | 48.56% | 32.73% | 33.45% | 81.39% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | -0.03% | 0.21% | Upgrade
|
| Total Shareholder Return | 5.58% | 6.08% | 6.35% | 7.24% | 5.71% | 9.13% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.